A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors - Join Clinical Trial NCTNCT05683418
How to Join This Clinical Trial - NCTNCT05683418
Learn how to participate in this PHASE1 trial studying an investigational therapy for Breast Neoplasms, Endometrial Neoplasms, Squamous Cell Carcinoma of Head and Neck. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Breast Neoplasms, Endometrial Neoplasms, Squamous Cell Carcinoma of Head and Neck. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Breast Neoplasms, Endometrial Neoplasms, Squamous Cell Carcinoma of Head and Neck
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE1 - Early safety study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT05683418 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 18 locations. Find a study site near you:
Clinical Research Site
Los Angeles, California 90033 - United States
Status: RECRUITING
Clinical Research Site
Chicago, Illinois 60611 - United States
Status: RECRUITING
Clinical Research Site
Boston, Massachusetts 02114 - United States
Status: RECRUITING
Clinical Research Site
Boston, Massachusetts 02215 - United States
Status: RECRUITING
Clinical Research Site
Boston, Massachusetts 02215 - United States
Status: RECRUITING
Clinical Research Site
Oklahoma City, Oklahoma 73104 - United States
Status: RECRUITING
Clinical Research Site
Philadelphia, Pennsylvania 19106 - United States
Status: RECRUITING
Clinical Research Site
Nashville, Tennessee 37232 - United States
Status: RECRUITING
Clinical Research Site
Fairfax, Virginia 22031 - United States
Status: RECRUITING
Clinical Research Site
Barcelona, 08023 - Spain
Status: RECRUITING
And 8 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE1 clinical trial for Breast Neoplasms, Endometrial Neoplasms, Squamous Cell Carcinoma of Head and Neck:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships